Drugs / HD203
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01894412 | Jul 2013 → Dec 2015 | — | Hanwha Chemical | Completed | No outcome recorded |
| Phase 1 | NCT01431404 | Aug 2011 → Mar 2012 | — | Hanwha Chemical | Completed | No outcome recorded |
| Phase 1 | NCT01044836 | Jan → Jul 2010 | — | Hanwha Chemical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HD203 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01044836 ↗ |
| Route | Subcutaneous | “HD203 with those of etanercept after subcutaneous injection in healthy male volunteers” NCT01044836 ↗ |